Poloxamer Market Study Report Based on Size, Shares, Opportunities, Industry Trends and Forecast to 2027

In bioprocess applications, poloxamers are used in cell culture media for their cell cushioning effects because their addition leads to less stressful shear conditions for cells in reactors, which will lead to market growth.

According to the current analysis of Reports and Data, the global  poloxamer market  is expected to reach USD 38,735.0 million by year 2026, in terms of value at a CAGR of 6.4%. The varying length of polymer blocks gives rise to different polymers identified as 124, 188, 237, 338 and 407 among others showing a slight difference in their properties. The size and structure of poloxamers assemblies, and their adsorption properties have made them useful in many applications, including: drug delivery, nanoparticle synthesis, cosmetics and emulsion formulation, effective dispersants for ink/pigments and as versatile anti-bio fouling coatings, to name a few.

Poloxamers can be used to increase the water solubility of hydrophobic, oily substances or otherwise increase the miscibility of two substances with different hydrophobicities. Owing to this property, poloxamers are commonly used in industrial applications, cosmetics, and pharmaceuticals. They have also been evaluated for various drug delivery applications and were shown to sensitize drug-resistant cancers to chemotherapy. In bioprocess applications, poloxamers are used in cell culture media for their cell cushioning effects because their addition leads to less stressful shear conditions for cells in reactors.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1696

The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.

The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter's Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launch and brand promotions.

Key companies profiled in the report include:

BASF, Anshul Life Sciences, DeWolf Chemicals, Solvay, Sirion Biotech Gmbh, BioPharm International, Sigma-Aldrich, Planet Science, SpecialChem. BASF 

Market Segmentation by Types:

Grade (Volume, Kilo Tons; 2019-2026 and Revenue, USD Million; 2019-2026)

• Poloxamer 68
• Poloxamer 88
• Poloxamer 98
• Poloxamer 108
• Poloxamer 124
• Poloxamer 188
• Poloxamer 237
• Poloxamer 338
• Poloxamer 407

Method (Volume, Kilo Tons; 2019-2026 and Revenue, USD Million; 2019-2026)

• Direct Solubilization
• Thin Film methods
• Temperature-induced emulsification

Application (Volume, Kilo Tons; 2019-2026 and Revenue, USD Million; 2019-2026)

• Biotechnological Activity
• Brain Injury Treatment
• DNA Delivery
• Microbiological Activity
• Cardiovascular Treatment
• Others

End-Use (Volume, Kilo Tons; 2019-2026 and Revenue, USD Million; 2019-2026)

• Pharmaceutical Industry
• Biotechnological Companies
• Research Centers
• Others

Order this Report @ https://www.reportsanddata.com/report-pricing/1696

Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Poloxamer market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• Italy
• France
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East Africa
• Saudi Arabia
• UAE
• South Africa
• Rest of MEA

Further key findings from the report suggest

• The grade 338 segment is expected to grow at a CAGR of 5.1% till 2026. The significant share is due to the use of this grade of the compound as surfactants in pharmaceuticals and personal care products. However, a CIR (Cosmetic Ingredient Review) Expert Panel evaluated and concluded that 338 grade, consumed at 5.0 g/kg/day, produced slight transient diarrhea whereas it produced no adverse effects at 0.2 or 1.0 g/kg/day.
• The emulsification method that poloxamers allows for lower processing temperatures. The drug and solubilizing agent form an oily phase, which is encapsulated by the poloxamer. Multi-layer particles can be easily manufactured with this method. For instance, by first creating a mixture of drug with Tween 80 (poly (ethylene oxide) sorbitan monooleate) and soybean oil, more abundant, lipidlike aggregates can be formed and then these encapsulated by poloxamer.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1696

Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We constantly update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]